This year's HIMSS conference featured many news announcements — from advanced partnerships to product launches to new research. In this list, MedCity News compiled short summaries for six of the conference's most notable announcements.
Baxter International is selling its kidney care business for less than it was able to fetch for its much smaller biopharma solutions segment last year. A unit within kidney care took a goodwill impairment charge, Baxter’s financial reports show.
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.
Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.
Baxter International, a medical device company, and Matter, a health technology incubator, will work together to improve healthcare quality and value.
Bristol-Myers Squibb files a lawsuit against a former executive and Mayo Clinic pairs with Baxter's venture arm in biotech launch.